California Drug Testing Laws & Workplace Regulations

California Drug Testing Laws for Employers: A DOT and Non DOT Compliance Guide

California is the most restrictive drug testing environment in the United States. Between a constitutional right to privacy that applies to private employers, a body of case law limiting suspicionless testing, and recent legislation that fundamentally changed how cannabis results can be used, California employers face rules that do not exist anywhere else.

At US Drug Test Centers, we spend more time on California policy work than on any other state. The good news is that a compliant California program is entirely achievable. The bad news is that a policy copied from a Texas or Florida operation will almost certainly be unlawful here.

The DOT Exemption Is Your Anchor

Before covering California's restrictions, understand what they do not touch.

Federal DOT testing under 49 CFR Part 40 is unaffected by California law. California cannot restrict, modify, or override federal transportation testing requirements. The state's cannabis employment protections, discussed below, expressly do not apply where testing is required by federal law or as a condition of receiving federal funding, licensing, or contracting.

This means your DOT program in California looks exactly like your DOT program in Alabama. Your non DOT program does not.

DOT Drug and Alcohol Testing in California

California has the largest DOT regulated workforce in the country: port drayage operations at Los Angeles and Long Beach, agricultural and interstate trucking through the Central Valley, major aviation hubs, extensive transit systems, rail, pipeline, and maritime operations.

• Covered Populations The Federal Motor Carrier Safety Administration covers CDL drivers. The Federal Aviation Administration covers pilots, flight crew, mechanics, dispatchers, and other aviation safety sensitive personnel. The Federal Transit Administration covers employees at federally funded transit agencies including LA Metro, BART, Muni, and regional systems. The Federal Railroad Administration covers rail employees. The Pipeline and Hazardous Materials Safety Administration covers pipeline personnel. The U.S. Coast Guard covers commercial vessel crewmembers.
• The Federal Panel DOT testing uses a five panel urine screen at a laboratory certified by the Department of Health and Human Services, covering marijuana, cocaine, opiates including hydrocodone, hydromorphone, oxycodone, and oxymorphone, amphetamines including methamphetamine and MDMA, and phencyclidine. Alcohol testing uses evidential breath testing devices, with 0.04 as the violation threshold and 0.02 triggering removal from duty. All non negative results receive Medical Review Officer review.
• Required Testing Pre employment, random at federally set annual rates, reasonable suspicion by trained supervisors, post accident under agency criteria, and return to duty and follow up testing under a Substance Abuse Professional.
• Clearinghouse California motor carriers must run pre employment full queries and annual limited queries in the FMCSA Drug and Alcohol Clearinghouse and report violations and refusals.

California Cannabis Law Does Not Apply Here This is the single most important point for California employers with mixed workforces. A DOT covered driver who tests positive for marijuana is removed from safety-sensitive duty regardless of California law, regardless of a physician's recommendation, and regardless of whether the use occurred off duty in a fully legal context. Government Code section 12954 expressly exempts positions requiring testing under federal law.

Non DOT Drug Testing Laws in California

• AB 2188 and the Cannabis Metabolite Rule Assembly Bill 2188, effective January 1, 2024, added section 12954 to the Government Code and amended the Fair Employment and Housing Act. It made two things unlawful for covered employers. First, it is unlawful to discriminate against a person in hiring, termination, or any term or condition of employment based on that person's use of cannabis off the job and away from the workplace. Second, and more consequentially for testing programs, it is unlawful to discriminate based on an employer required drug screening test that has found the person to have nonpsychoactive cannabis metabolites in their hair, blood, urine, or other bodily fluids. That second provision is the one that changed California testing practice. Standard urine and hair testing detect carboxy THC, a nonpsychoactive metabolite that can persist for days or weeks after use. Under AB 2188, a result of that kind generally cannot be the basis for an adverse employment action in a covered non DOT position. The statute preserves the employer's right to maintain a drug and alcohol free workplace and to prohibit possession, impairment, and use during work hours. What it removes is the ability to treat a metabolite positive as proof of a workplace violation. Employers who need to screen for cannabis in California non DOT roles should be using methods that identify psychoactive THC rather than inactive metabolites, such as oral fluid testing designed for that purpose. We help California clients restructure panels accordingly.
• SB 700 and Prior Cannabis Use Senate Bill 700, also effective January 1, 2024, amended the Fair Employment and Housing Act to make it unlawful for an employer to request information from an applicant relating to their prior use of cannabis. Employers also may not use information about prior cannabis use obtained from a criminal history where that information is otherwise protected under California law. Review your applications, interview scripts, and background check practices for compliance.
• Exemptions From the Cannabis Protections The protections do not apply to employees in the building and construction trades. They do not apply to applicants or employees hired for positions requiring a federal government background investigation or security clearance. And they do not preempt state or federal laws requiring testing for controlled substances as a condition of employment, receiving federal funding or licensing benefits, or entering into a federal contract.
• The California Constitutional Right to Privacy Article I, Section 1 of the California Constitution creates a right to privacy that applies to private employers, not just government actors. This is unusual and it materially shapes California testing law. California courts have generally upheld pre employment drug testing of applicants, reasoning that applicants have reduced privacy expectations and that testing at the conditional offer stage is a limited intrusion. Loder v. City of Glendale is the leading authority on this point. Random or suspicionless testing of current employees is treated very differently. California courts weigh the intrusion against the employer's interest, and outside of genuinely safety sensitive positions, suspicionless random testing of incumbent non DOT employees carries substantial legal risk. Employers who want a random program for non DOT staff in California should not assume it is defensible without careful, position by position justification. Reasonable suspicion and post accident testing are on much firmer ground, provided they are based on documented, individualized, articulable facts.
• Medical Cannabis and Accommodation California's Compassionate Use Act does not require accommodation of cannabis use, and Ross v. RagingWire Telecommunications held that employers were not required to accommodate medical marijuana. AB 2188 has significantly reshaped the practical landscape, but employers should be aware that the underlying accommodation analysis for the treated condition, as opposed to the cannabis itself, still runs through FEHA disability law.
• Local Ordinances California employers should also check municipal requirements. Some jurisdictions have adopted additional restrictions on pre employment cannabis screening and on the timing of testing relative to conditional offers.

Practical Steps for California Employers

Separate your DOT and non DOT programs completely and document the basis for every DOT designation. Remove cannabis metabolite testing from non DOT panels unless an exemption clearly applies, or switch to a method that detects psychoactive THC. Scrub applications and interview materials of questions about prior cannabis use. Limit non DOT random testing to positions with a defensible safety sensitive justification, or eliminate it. Build reasonable suspicion procedures around documented observation by trained supervisors. Test applicants only after a conditional offer. Apply the policy uniformly. Have California counsel review the policy before implementation, and review it annually.

How US Drug Test Centers Supports California Employers

We operate collection sites throughout Los Angeles, San Diego, San Francisco, Sacramento, and more across the state. We provide certified laboratory analysis, Medical Review Officer services, DOT random pool management, Clearinghouse support, supervisor reasonable suspicion training, and panel design and policy development built specifically around California's AB 2188 and SB 700 requirements..

Contact US Drug Test Centers to bring your California program into compliance.